A Single Amino Acid Residue Constitutes the Third Dimerization Domain Essential for the Assembly and Function of the Tetrameric Polycystin-2 (TRPP2) Channel by Feng, S. et al.
A Single Amino Acid Residue Constitutes the Third
Dimerization Domain Essential for the Assembly and
Function of the Tetrameric Polycystin-2 (TRPP2) Channel*
Received for publication,October 7, 2010, and in revised form, March 2, 2011 Published, JBC Papers in Press, April 7, 2011, DOI 10.1074/jbc.M110.192286
Shuang Feng‡1, Lise Rodat-Despoix§, Patrick Delmas§, and Albert C. M. Ong‡2
From the ‡Kidney Genetics Group, Academic Unit of Nephrology, The HenryWellcome Laboratories for Medical Research,
University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, United Kingdom and the §Centre de Recherche en
Neurophysiologie et Neurobiologie deMarseille, UMR 6231, CNRS, Universite´ de la Me´diterrane´e, CS80011, Bd. Pierre Dramard,
13344 Marseille Cedex 15, France
Autosomal dominant polycystic kidney disease (ADPKD), the
most common inherited cause of kidney failure, is caused by
mutations in either PKD1 (85%) or PKD2 (15%). The PKD2 pro-
tein, polycystin-2 (PC2 or TRPP2), is a member of the transient
receptor potential (TRP) superfamily and functions as a nonse-
lective calcium channel. PC2 has been found to form oligomers
in native tissues, suggesting that similar to other TRP channels,
it may form functional homo- or heterotetramers with other
TRP subunits. We have recently demonstrated that the homo-
dimerization of PC2 is mediated by both N-terminal and C-ter-
minal domains, and it is known that PC2 can heterodimerize
with PC1, TRPC1, and TRPV4. In this paper, we report that a
single cysteine residue, Cys632, mutated in a known PKD2 ped-
igree, constitutes the third dimerization domain for PC2. PC2
truncation mutants lacking both N and C termini could still
dimerize under nonreducing conditions. Mutation of Cys632
alone abolished dimerization in thesemutants, indicating that it
was the critical residue mediating disulfide bond formation
between PC2 monomers. Co-expression of C632A PC2 mutants
with wild-type PC2 channels reduced ATP-sensitive endoplasmic
reticulum Ca2 release in HEK293 cells. The combination of
C632A and mutations disrupting the C-terminal coiled-coil
domain (Val846, Ile853, Ile860, Leu867 or 4M)nearly abolisheddimer
formation and ATP-dependent Ca2 release. However, unlike the
4M PC2 mutant, a C632Amutant could still heterodimerize with
polycystin-1 (PC1). Our results indicate that PC2 homodimeriza-
tion is regulated by three distinct domains and that these events
regulate formation of the tetrameric PC2 channel.
Autosomal dominant polycystic kidney disease (ADPKD)3
accounts for 10% of patients on renal replacement therapy
and is therefore an important cause of end-stage renal failure
worldwide. It is the most common inherited human renal dis-
ease and results from germ line mutations in either PKD1 or
PKD2 (1). The cardinal feature of the ADPKD kidney is the
presence of multiple fluid-filled cysts. However, cysts can arise
in other epithelial structures such as the liver and pancreas.
Variable expression of noncysticmanifestations such as cardiac
valve abnormalities, diverticular disease, and intracranial aneu-
rysms have been described in this condition (2).
Mutations in PKD2 account for 15% of all patients with
ADPKD. The PKD2 protein, polycystin-2 (PC2), is a type II
membrane protein with the properties of a high conductance
nonselective Ca2-permeable cation channel (3). PC2 (or
TRPP2) has been included in the TRP (transient receptor
potential) superfamily of channels due to its sequence homol-
ogy to other TRP channels (4, 5). Its major site of action within
the cell has been debated with evidence of ciliary, basolateral,
and ER locations reported. In primary cilia, PC2 forms a flow-
activated mechanosensitive channel complex in association
with PC1 and/or TRPV4 (6, 7). At the basolateral membrane,
PC2 (with PC1) could be implicated in cell-cell or cell-matrix
adhesion, including possibly in mechanotransduction (8, 9).
PC2 has also been shown to function as an ER Ca2 release
channel, in association with inositol trisphosphate and ryano-
dine receptors in different studies (10–12).
The finding of PC2 oligomers in native tissues indicated that
similar to other TRP channels, PC2 channel assembly was likely
to involve homodimerization and heterodimerization (8). PC2
interacts with PC1 in vitro and in vivo to form a stable heterodi-
meric complex (8). Interactions between the two proteins may
regulate their trafficking, and there is evidence for reciprocal
activation or inhibition of activity in different experimental sys-
tems (13–15). PC2 is also likely to function independently of
PC1 in determining left-right asymmetry at the embryonic
node (16). Interactions between PC2 and two other TRP chan-
nel subunits, TRPC1 andTRPV4, have also been reported (5, 7).
The physiological function of PC2-TRPC1 channels is
unknown, although it has distinct properties from homomeric
PC2 and TRPC1 channels (17). A role in cutaneous thermosen-
sation has been reported for PC2-TRPV4 channels (7).
In recent papers, we have described two distinct domains
involved in PC2 homodimerization (18, 19). The C-terminal
coiled-coil domain (CC2) specifically mediates C-terminal
homodimerization, and this event is critical for PC1 recogni-
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tion andbinding (19). PC2CC2mutantswere unable to interact
with PC1 but were still able to dimerize via an N-terminal
dimerization domain to form tetrameric ATP-sensitive ER
Ca2 release channels (19). In this paper, we report a third
dimerization domain for PC2. Mutation at a single cysteine
residue, Cys632, abolishes disulfide bond-dependent dimeriza-
tion and impairs PC2 channel function.
EXPERIMENTAL PROCEDURES
Materials—All chemicals were purchased from Sigma unless
otherwise stated.
Generation of PKD2 Plasmids—Unless otherwise stated, the
PKD2 plasmids used in this paper have been reported previ-
ously (18–21). C-terminal Pk-tagged full-length PKD2 trunca-
tions were subcloned into pcDNA3 by PCR and ligation using
the restriction sites XhoI and XbaI. Three truncation clones
were generated: clone 1 had PKD2(224–968), clone 2 had
PKD2(469–968), and clone 3 had PKD2(224–679). Site-spe-
cific mutations were introduced into full-length PKD2 and its
truncations using the QuikChange Site-directed Mutagenesis
protocol (Stratagene) as described previously. All changes were
verified by nucleotide sequencing.
Immunoblotting and Immunoprecipitation—HEK293 cells
were cultured in DMEM supplemented with 10% fetal bovine
serum (FBS). Transient transfection was carried out on cells
cultured to 60–80% confluence using GeneJuice transfection
reagent (Novagen) according to the manufacturer’s instruc-
tions. Immunoblotting and immunoprecipitation (IP) were
performed as described previously using epitope-specific anti-
bodies (8). 10g of total proteinwas loaded per lane, and IPwas
performed from 500 g of total protein. Samples were sepa-
rated on a 5% SDS-polyacrylamide gel under reducing and
nonreducing conditions. The PC2 antibody, p30, generated to
the C-terminal 258 amino acids of human PC2, and the PC1
mAb (7e12) have been reported previously (20, 22). The goat
polyclonal PKD2 antibody G20 (sc-10376) was purchased from
Santa Cruz Biotechnology (Santa Cruz, CA).
Oxidation of Cysteine Residues and Disulfide Bond Forma-
tion—HEK293 cells were transfected with the pcDNA3-Pk-
PC2(224–679) plasmid and lysates prepared after 48 h. To
specifically oxidize cysteine residues, performic acid was freshly
prepared by mixing 1 volume of 30% H2O2 with 9 volumes of
100% formic acid and incubated at room temperature for 1 h
(23). Performic acid was then added toHEK293 lysates at a 1:80
ratio (v/v) and neutralized with 5 M NaOH at a similar ratio
prior to loading in nonreducing buffer. In parallel, cell lysates
were treated with the reducing agents DTT (2 mM) or -mer-
captoethanol (5%), respectively, for 30 min to disrupt disulfide
bonds. 15 g of protein of each sample was resolved on 7.5%
SDS-PAGE prior to immunodetection with an anti-Pk tag
antibody.
Transfection of HEK293T Cells and Calcium Imaging—
HEK293T cells were cultured as described previously (19).
Briefly, HEK293T cells were maintained in DMEM-HEPES
(GlutaMAXTM-l, 4,500 mg/liter glucose, 25 mMHEPES buffer)
supplemented with 10% decomplemented fetal bovine serum,
1% MEM nonessential amino acids, and 1% sodium pyruvate.
Cells at 60% confluence were transfected by Jet PEI (Polyplus
transfection) or Lipofectamine 2000 (Invitrogen) in 0.7-cm2
wells coated with poly-L-lysine (5 g/ml) or in 100-mm dishes.
Coverslips with HEK293T cells were loaded with fura-PE3/AM
(2 M) for 30 min (37 °C, 5% CO2) in culture medium. Glass
coverslips were then individually inserted in a specific chamber
(Harvard Apparatus) and placed on the stage of an inverted
epifluorescence microscope (Olympus IX71) equipped with a
X40, UApo/340–1.15Wwater-immersion objective. Fura-PE3
was alternately excited at 345 and 380 nm, and ratios of the
resulting images (345/380) were produced every 5 s. The source
of excitation light was a xenon arc lamp, and excitation wave-
length was selected by a fast excitation filter wheel (Illumina-
tion SystemsMT20; Olympus). Digital images were sampled at
12-bit resolution by a fast-scan, cooled charge-coupled device
(B/W CCD) digital camera (Orca-ER, Hamamatsu). All images
were background-subtracted and controlled by Cell-R software
(Olympus).
The 340/380 ratios of emitted fura-PE3/AM fluorescence
were calibrated using the standard equation of Grynkiewicz
(24), [Ca2]Kd ((R Rmin)/(Rmax R)), where R is the
fluorescence ratio recorded at the two excitation wavelengths
(F340 and F380), Kd represents the apparent dissociation con-
stant of fura-PE3/AM for Ca2 (266 nM), Rmin and Rmax are the
fluorescence ratios under Ca2-free and Ca2-saturating (5
mM) conditions and  F380, zero Ca2/F380, saturating Ca2
(24). The calibration was performed by perfusing HEK293T
cells with 5M ionomycin during 15min before bath perfusion
of solutions containing no calcium (0 mM Ca2 and 5 mM
EGTA) or 5 mM Ca2 (with no EGTA added). Data calibration
was then confirmed by measuring the emitted fura-PE3/AM
fluorescence in the presence of known Ca2 concentrations
ranging from 0 to 39 M (data not shown) (Molecular Probes).
RESULTS
Identification of a Third Dimerization Domain for PC2—We
recently reported the existence of two separate N- and C-ter-
minal dimerization domains for PC2 important for channel
assembly and activity (18, 19). To clarify the relative role of each
domain for PC2 self-association, we initially deleted the entire
N terminus from full-length PC2 (Pk-PC2(224–968)) (Fig. 1A).
Surprisingly, this showed a very similar pattern to wild-type
PC2 with prominent dimer and tetramer formation. The intro-
duction of four substitution mutations (Val846, Ile853, Ile860,
Leu867 or 4M) in the C-terminal CC2 has been shown to spe-
cifically disrupt C-terminal dimerization and abolish PC2
binding to PC1 (19). As shown in Fig. 1A, CC2 mutations also
markedly reduced PC2 oligomerization to a predominant
monomeric form, as seen with wild-type PC2. Deletion of the
N-terminal domain did not completely abolish dimer forma-
tion in this protein. Furthermore, the combined deletion of
both N- and C-terminal domains (Pk-PC2 (224–679)) permit-
ted the formation of dimers under nonreducing conditions (Fig.
2B). These results indicated the existence of a third dimeriza-
tion domain within the transmembrane region of PC2 between
amino acids 224 and 679.
Deletion of the First Extracellular Loop Does Not Abolish
Dimer Formation—In view of the sensitivity of PC2 dimeriza-
tion to reducing agents, we hypothesized that cysteine residues
A Third Dimerization Domain for Polycystin-2
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within the putative extracellular loops of plasma membrane
located PC2 (or the intraluminal loops for ER localized PC2)
weremost likely to bemediating PC2 dimerization through the
formation of disulfide bonds. The first loop (amino acids 245–
468) contains three cysteine residues at cysteines 331, 344, and
437.
We initially deleted the entire N-terminal region including
the first extracellular loop (amino acids 1–468) in combination
with a deletion of the C-terminal domain (amino acids 679–
968). However, this mutant protein was highly unstable when
expressed in HEK293 cells (data not shown). We therefore
revised our strategy to generate a deletion construct omitting
the N-terminal and first loop deletion (Pk-PKD2(469–968))
only. As shown in Fig. 1B, deletion of the first loop did not alter
dimer or tetramer formation. Once again, introduction of CC2
mutations (4M) markedly reduced but did not abolish dimer
formation under nonreducing conditions though tetramers
were not visualized (Fig. 1B). These results indicate that the first
loop is not involved in mediating homodimerization.
A Single Cysteine Residue in the Third Extracellular Loop
Constitutes the Third Dimerization Domain—We next sought
to investigate the role of other cysteine residues in either the
second (amino acids 527–550) or third (amino acids 620–658)
extracellular loops. There is a single cysteine residue in the
third loop (Cys632) which has been reported to be mutated in a
PKD2pedigree (C632R) (25).Of relevance, this residue is highly
conserved between human and worm PC2 protein (Fig. 2A). It
also lies within the predicted pore forming region although no
functional assays had been previously performed.
We generated a site-specific C632A mutation in a construct
with both N- and C-terminal domains deleted (Pk-PKD2(224–
679)). Deletion of both domains had no effect, but the C632A
mutation completely abolished dimer formation in the absence
of both N- and C-terminal domains under nonreducing condi-
tions (Fig. 2B). In contrast, mutation of an irrelevant residue
(P546A) in the second extracellular loop had no effect (Fig. 2B).
Incubation of the Pk-PKD2(224–679)) protein with oxidizing
or reducing agents confirmed that dimer formation was medi-
ated by disulfide bonds between two cysteine residues (Fig. 2C).
Introduction of the C632A mutation into full-length PC2
shifted the ratio between monomers and dimers to the mono-
meric form with no tetramers seen (Fig. 2D). Under the same
conditions, wild-type PC2 showed prominent dimers and
tetramers (Fig. 2D). However, a C632R mutant had an oligo-
merization pattern intermediate betweenwild type andC632A.
The reason for the difference between the C632A and C632R
mutants is unclear. CC2 mutations (4M) had a more marked
effect than C632A on dimer formation. Dimer formation was
almost completely abolished in the combined mutant
(C632A4M), although a faint dimer band presumably due to
theN-terminal dimerization domain could still be visualized on
prolonged exposure (Fig. 2D).
Mutations of Cys632 Do Not Alter Formation of the PC1-PC2
Complex—Mutations of CC2 (4M) have been shown to abolish
PC1 recognition and formation of a functional PC1-PC2 recep-
tor-ion channel complex (19). We examined whether a C632A
or C632Rmutation would affect PC1 binding. As shown in Fig.
2D, PC1 bound normally to PC2 C632A and C632R mutants
but not to PC2–4M in co-IP assays. These results confirm that
binding to PC1 is specifically determined by C-terminal
dimerization through the CC2 (Fig. 2E). It seems likely that the
role ofCys632-mediated dimerization is in the assembly of tetra-
meric PC2 channels rather than the heteromeric PC1-PC2
channel complex.
Mutations of Cys632 Reduce ATP-sensitive Ca2 Release from
ER-located PC2 Channels—We have recently shown that PC2
channels can function as receptor-operated ER located homo-
meric Ca2 release channels independently of PC1 (19). Based
on these findings, we compared Ca2 release from intracellular
stores in response toATP (400M) in cells expressingwild-type
PC2 (PC2wt) and cells expressing PC2-C632A, PC2wtPC2-
C632A, PC2–4M, and PC2-C632A4M mutants (Fig. 3).
Compared with cells expressing wild-type PC2 ([Ca2],
182.06  21.18, n  94), ATP-mediated Ca2 transients had
significantly (p  0.01) smaller amplitudes in cells expressing
PC2-C632A ([Ca2], 86.66  9.20, n  82), PC2wtPC2-
C632A ([Ca2], 111.39  4.60, n  83), PC2–4M ([Ca2],
76.04  10.74, n  22), and PC2-C632A4M ([Ca2],
57.72  15.68, n  31). We confirmed that Ca2 release was
mediated by ER PC2 by expressing the channel-dead mutant
FIGURE 1. Evidence of a third dimerization domain for PC2. A, expression
pattern of epitope-taggedmutant PC2 on nonreducing SDS-PAGE. The trun-
cation mutant PC2(224–968), which lacks the N terminus (1–223), is still able
to form homodimers and tetramers. Mutation of CC2 (4M) in this construct
results in a predominant monomeric pattern with faint but detectable
dimers. Calnexin was used as an endogenous control for loading. B, deletion
of the N terminus and first extracellular loop (469–968) shows a migration
pattern similar to that of PC2(224–968) under nonreducing conditions.Muta-
tion of CC2 (4M) results in a predominant monomeric pattern with faint
dimers. C, diagram of PC2 showing its likely topology and key residues. The
N-terminal dimerization domain (NTDD), coiled coil domains 1 (CC1) and 2
(CC2) within the C terminus have been described previously.
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PC2-D511V. In these cells, the ATP-induced Ca2 rise
([Ca2], 83.37 16.25, n 55) was not significantly different
from ATP responses obtained in cells expressing EGFP alone
([Ca2], 43.24 5.68, n 22). These data indicate that resi-
due Cys632 has a key role in the formation of functional ER
tetrameric PC2 channels.
DISCUSSION
Mutations in PKD1 and PKD2 give rise to ADPKD whose
clinical phenotype is characterized by the formation of fluid-
filled cysts in the kidney and other organs as well as the pres-
ence of noncystic manifestations such as vascular aneurysms
and cardiac valve defects. PC1 and PC2 have been shown to
interact via their C-terminal domains (26, 27), and a native
PC1-PC2 complex has been identified (8). It seems likely there-
fore that signals resulting from the interaction between both
proteins are critical to themaintenance of normal kidney struc-
ture and function.
PC2 is known to form oligomers in native cells and tissues
(8), and there is evidence that PC2 can function independently
of PC1 at the embryonic node in the determination of body axis
patterning (16). It is unclear whether this PC2-specific function
is mediated by PC2 ciliary complexes or by PC2-ER complexes
because there is evidence for the involvement of both in differ-
ent studies (16, 19, 28). Unusually for TRP channels, PC2 has
also been reported to interact with subunits from other TRP
subfamilies such as TRPC1 and TRPV4 which co-localize to
primary cilia (7, 17). PC2 interacts via its C terminus with the C
termini of TRPC1 and TRPV4 (Fig. 4). In addition, PC2 and
TRPC1 reportedly interact through their transmembrane
regions, although it is unclear whether this interaction is direct
(5). The physiological significance of these ciliary and/or
FIGURE 2.A conserved cysteine residue in the third extracellular loopmediates PC2dimerization.A, sequence alignment of Cys632 showing its complete
evolutionary conservation from human to Caenorhabditis elegans PC2. B, expression pattern of epitope-tagged mutant PC2 on nonreducing SDS-PAGE.
Deletion of both N- and C-terminal domains, PC2(224–679), does not abolish dimer formation. Mutation at Cys632 but not Pro546 abolishes the formation of
dimer formation in the absence of the two knowndimerization domains. C, cell lysates of PC2(224–679) resolved on SDS-PAGE. Lysateswere either incubated
under nonreducing conditions, reducing agents (-mercaptoethanol, DTT), or performic acid prior to loading. Immunoblottingwaswith anti-Pk tag antibody.
D, expression pattern of epitope-tagged full-length PC2 on nonreducing SDS-PAGE. Wild-type PC2 migrates most prominently with dimeric and tetrameric
species. The C632A mutation abolished tetramer bands but with an equal ratio of monomers and dimers. The double mutation (C632A4M) almost com-
pletely abolished dimer formation. The pattern observed with C632R was intermediate between wild type and C632A. E, immunoprecipitation assays with
epitope-tagged full-length PC1 and PC2. Mutation at C632A or C632R did not affect the PC1-PC2 interaction, whereas CC2mutations (4M) abolished PC1-PC2
interactions.
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plasma membrane complexes in kidney function is not yet
clear. Mice deficient in TRPC1 and TRPV4 do not develop kid-
ney cysts.
Functional interactions between PC2 and other major ER
Ca2 release channels such as the inositol trisphosphate recep-
tor and the type II ryanodine receptor (in cardiac tissue) have
also been reported (11, 12, 29). PC2 binds via its C terminus to
both receptors, although possibly to the ryanodine receptor in
its open state (Fig. 4). An additional N-terminal binding site for
PC2 to the ryanodine receptor has been described (12). Again,
the functional significance of these ER complexes is uncertain.
In addition, the precise stoichiometry of the various PC2 com-
plexes has not been resolved.
In this paper, we report that PC2 homodimerization is regu-
lated by a third dimerization domain. In recent studies, we
reported the existence of a new N-terminal dimerization
domain (18) and with others, a previously unrecognized C-ter-
minal CC2 for PC2 (19, 30, 31). Although there is disagreement
as towhether the latter leads to dimerization or trimerization of
the PC2 C terminus, oligomerization of PC2 appears to be an
absolute requirement for PC1 binding (19, 30). The specificity
of CC2 in mediating PC2 dimerization for PC1 recognition is
FIGURE 3. The Cys632 mutation abrogates ATP-dependent PC2 Ca2 release channel activity. A–D, averaged calcium transients in response to ATP
application (400 M) in HEK293T cells expressing EGFP (A), EGFP PC2 (B), EGFP PC2-C632A (C), and EGFP PC2-C632A4M (D). The gray horizontal bars
indicatedurationofATPapplication. E, histogramshowing the average rise in [Ca2]i inducedbyATP in cells expressingEGFP (0.5gof cDNA), EGFPPC2 (0.5
g of cDNA), EGFP PC2-C632A, EGFP PC2 PC2-C632A, EGFP PC2–4M, EGFP PC2-C632A4M and EGFP PC2-D511V. Bars represent mean S.E.
*, p 0.05; **, p 0.01.
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confirmed by the lack of effect of the Cys632 mutants in this
study.
Previously, we showed that PC2 mutants unable to undergo
C-terminal dimerization (PC2–4M) were still able to form ER-
based Ca2 release channels and could partially rescue the LR
defect seen in zebrafish embryos though not the cystic pro-
nephric kidney (19). These results indicated that although
C-terminal dimerization is specific to the formation of PC1-
PC2 heteromers, other upstream dimerization regions (includ-
ing the N-terminal domain) are critical to the formation of
homomeric PC2 complexes.Our results demonstrate that PC2-
C632A mutants have reduced ER PC2-mediated Ca2 release
similar to the PC2–4M mutants and predict that they will be
similarly functionally effective in rescuing the laterality defect.
In conclusion, we demonstrate that PC2 homodimerization
is regulated by three distinct domains and that these events
regulate formation of the tetrameric PC2 channel (Fig. 5). Our
results define a single cysteine residue, Cys632, known to be
mutated in a PKD2 pedigree, as a key functional residue regu-
lating PC2 channel activity (25). Cys632 lies in a putative third
extracellular loop (for plasma membrane channel) or third
intraluminal loop (for the ER channel) which constitutes part of
the predicted channel pore region for PC2.Our studies indicate
that it mediates disulfide bonding between PC2 monomers to
formhomodimers critical for the formation of tetrameric chan-
nels (Fig. 5). Co-expression of a C632A mutant suppressed the
effect of wild-type PC2 in ER Ca2 release assays, proving the
functional importance of this interaction. Of interest, a com-
bined mutant (C632A4M) retaining the N-terminal domain
had almost absent ATP-sensitive PC2-dependent Ca2 release.
In a previous study, we found that expression of the N-terminal
dimerization domain as a surface-anchored protein inmamma-
lian cells could inhibit plasma membrane PC2 channel activity
in mIMCD3 cells (18). These results imply that the N-terminal
dimerization domain is not critical for the function of ER PC2
channels but is required for the function of surface PC2 chan-
nels. In LLCPK-1 cells, surface PC2 can be activated via mem-
brane depolarization or EGF stimulation. This effect appears to
be mediated by the unblocking of PC2 by mDia-1 through its
activation by RhoA (32). It seems likely that distinct regulatory
pathways, possibly through altering key protein-protein inter-
actions, regulate the function of the ER and surface PC2
channels.
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